111.   The filing of the Food and Drug Administration application to market the drug, developed with partner Xoma Ltd., already has been delayed once.

112.   The company applied in July to the Food and Drug Administration for approval to market the drug.

113.   The company denies hiding information, and says it acted properly in marketing the drugs.

114.   The five-member tribunal said Vesco must also repay foreign investors who claimed they poured tens of thousands of dollars into producing and marketing the drug.

115.   The drug will be marketed by RepliGen Corp., which is conducting clinical trials of secretin and autism.

116.   The drug will be marketed in conjunction with Wyeth Ayerst Laboratories, a division of American Home Products, Elan said.

117.   The study was sponsored by the Food and Drug Administration and Orphan Medical of Minnetonka, Minn., which markets the drug, sold under the name Antizol.

118.   The recommendation goes to the European Commission, which will decide whether to grant Amgen a license to market the drug throughout the EU.

119.   The research was not paid for by any of the drug companies that market the drugs worldwide.

120.   The work was financed by Glaxo Wellcome Inc., which markets the drug as Wellbutrin SR.